DCE@urLAB: a Dynamic Contrast-enhanced MRI Pharmacokinetic Analysis Tool for Preclinical Data

Overview

Journal BMC Bioinformatics

Publisher Biomed Central

Specialty Biology

Date 2013 Nov 5

PMID 24180558

Citations 21

Authors

Juan E Ortuno

Maria J Ledesma-Carbayo

Rui V Simoes

Ana P Candiota

Carles Arus

Andres Santos

Affiliations

Soon will be listed here.

Abstract

Background: DCE@urLAB is a software application for analysis of dynamic contrast-enhanced magnetic resonance imaging data (DCE-MRI). The tool incorporates a friendly graphical user interface (GUI) to interactively select and analyze a region of interest (ROI) within the image set, taking into account the tissue concentration of the contrast agent (CA) and its effect on pixel intensity.

Results: Pixel-wise model-based quantitative parameters are estimated by fitting DCE-MRI data to several pharmacokinetic models using the Levenberg-Marquardt algorithm (LMA). DCE@urLAB also includes the semi-quantitative parametric and heuristic analysis approaches commonly used in practice. This software application has been programmed in the Interactive Data Language (IDL) and tested both with publicly available simulated data and preclinical studies from tumor-bearing mouse brains.

Conclusions: A user-friendly solution for applying pharmacokinetic and non-quantitative analysis DCE-MRI in preclinical studies has been implemented and tested. The proposed tool has been specially designed for easy selection of multi-pixel ROIs. A public release of DCE@urLAB, together with the open source code and sample datasets, is available at http://www.die.upm.es/im/archives/DCEurLAB/.

Citing Articles

Deuterium metabolic imaging phenotypes mouse glioblastoma heterogeneity through glucose turnover kinetics.

Simoes R, Henriques R, Olesen J, Cardoso B, Fernandes F, Monteiro M Elife. 2025; 13.

PMID: 40035743 PMC: 11879113. DOI: 10.7554/eLife.100570.

ImmunoPET imaging of TIGIT in the glioma microenvironment.

Vincze S, Jaswal A, Frederico S, Nisnboym M, Li B, Xiong Z Sci Rep. 2024; 14(1):5305.

PMID: 38438420 PMC: 10912309. DOI: 10.1038/s41598-024-55296-y.

Therapeutic effect of 7 nicotinic receptor activation after ischemic stroke in rats.

Aguado L, Joya A, Garbizu M, Plaza-Garcia S, Iglesias L, Hernandez M J Cereb Blood Flow Metab. 2023; 43(8):1301-1316.

PMID: 36916034 PMC: 10369150. DOI: 10.1177/0271678X231161207.

qMRI-BIDS: An extension to the brain imaging data structure for quantitative magnetic resonance imaging data.

Karakuzu A, Appelhoff S, Auer T, Boudreau M, Feingold F, Khan A Sci Data. 2022; 9(1):517.

PMID: 36002444 PMC: 9402561. DOI: 10.1038/s41597-022-01571-4.

Metal-Free Radical Dendrimers as MRI Contrast Agents for Glioblastoma Diagnosis: and Approaches.

Zhang S, Lloveras V, Lope-Piedrafita S, Calero-Perez P, Wu S, Candiota A Biomacromolecules. 2022; 23(7):2767-2777.

PMID: 35749573 PMC: 9277593. DOI: 10.1021/acs.biomac.2c00088.

References

Wang H, Li J, Chen F, De Keyzer F, Yu J, Feng Y . Morphological, functional and metabolic imaging biomarkers: assessment of vascular-disrupting effect on rodent liver tumours. Eur Radiol. 2010; 20(8):2013-26. DOI: 10.1007/s00330-010-1743-5. View

Weidensteiner C, Rausch M, McSheehy P, Allegrini P . Quantitative dynamic contrast-enhanced MRI in tumor-bearing rats and mice with inversion recovery TrueFISP and two contrast agents at 4.7 T. J Magn Reson Imaging. 2006; 24(3):646-56. DOI: 10.1002/jmri.20676. View

Ahearn T, Staff R, Redpath T, Semple S . The use of the Levenberg-Marquardt curve-fitting algorithm in pharmacokinetic modelling of DCE-MRI data. Phys Med Biol. 2005; 50(9):N85-92. DOI: 10.1088/0031-9155/50/9/N02. View

Weiss W, Burns M, Hackett C, Aldape K, Hill J, Kuriyama H . Genetic determinants of malignancy in a mouse model for oligodendroglioma. Cancer Res. 2003; 63(7):1589-95. View

Port R, Knopp M, Hoffmann U, Milker-Zabel S, Brix G . Multicompartment analysis of gadolinium chelate kinetics: blood-tissue exchange in mammary tumors as monitored by dynamic MR imaging. J Magn Reson Imaging. 1999; 10(3):233-41. DOI: 10.1002/(sici)1522-2586(199909)10:3<233::aid-jmri3>3.0.co;2-m. View

Ferl G, Xu L, Friesenhahn M, Bernstein L, Barboriak D, Port R . An automated method for nonparametric kinetic analysis of clinical DCE-MRI data: application to glioblastoma treated with bevacizumab. Magn Reson Med. 2010; 63(5):1366-75. DOI: 10.1002/mrm.22335. View

Tofts P, Kermode A . Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts. Magn Reson Med. 1991; 17(2):357-67. DOI: 10.1002/mrm.1910170208. View

Yankeelov T, DeBusk L, Billheimer D, Luci J, Lin P, Price R . Repeatability of a reference region model for analysis of murine DCE-MRI data at 7T. J Magn Reson Imaging. 2006; 24(5):1140-7. DOI: 10.1002/jmri.20729. View

Kim J, Im G, Yang J, Choi D, Lee W, Lee J . Quantitative dynamic contrast-enhanced MRI for mouse models using automatic detection of the arterial input function. NMR Biomed. 2011; 25(4):674-84. DOI: 10.1002/nbm.1784. View

10.

Stefanovski D, Moate P, Boston R . WinSAAM: a windows-based compartmental modeling system. Metabolism. 2003; 52(9):1153-66. DOI: 10.1016/s0026-0495(03)00144-6. View

11.

Cetin O . An analysis tool to calculate permeability based on the Patlak method. J Med Syst. 2010; 36(3):1317-26. DOI: 10.1007/s10916-010-9592-y. View

12.

Collins D, Padhani A . Dynamic magnetic resonance imaging of tumor perfusion. Approaches and biomedical challenges. IEEE Eng Med Biol Mag. 2004; 23(5):65-83. DOI: 10.1109/memb.2004.1360410. View

13.

Kim H, Folks K, Guo L, Stockard C, Fineberg N, Grizzle W . DCE-MRI detects early vascular response in breast tumor xenografts following anti-DR5 therapy. Mol Imaging Biol. 2010; 13(1):94-103. PMC: 4138021. DOI: 10.1007/s11307-010-0320-2. View

14.

Luo Y, Jiang F, Cole T, Hradil V, Reuter D, Chakravartty A . A novel multi-targeted tyrosine kinase inhibitor, linifanib (ABT-869), produces functional and structural changes in tumor vasculature in an orthotopic rat glioma model. Cancer Chemother Pharmacol. 2011; 69(4):911-21. DOI: 10.1007/s00280-011-1740-7. View

15.

Pike M, Stoops C, Langford C, Akella N, Nabors L, Gillespie G . High-resolution longitudinal assessment of flow and permeability in mouse glioma vasculature: Sequential small molecule and SPIO dynamic contrast agent MRI. Magn Reson Med. 2009; 61(3):615-25. PMC: 3243360. DOI: 10.1002/mrm.21931. View

16.

Yankeelov T, Luci J, Lepage M, Li R, DeBusk L, Lin P . Quantitative pharmacokinetic analysis of DCE-MRI data without an arterial input function: a reference region model. Magn Reson Imaging. 2005; 23(4):519-29. DOI: 10.1016/j.mri.2005.02.013. View

17.

Barboriak D, MacFall J, Viglianti B, Dewhirst Dvm M . Comparison of three physiologically-based pharmacokinetic models for the prediction of contrast agent distribution measured by dynamic MR imaging. J Magn Reson Imaging. 2008; 27(6):1388-98. PMC: 3755278. DOI: 10.1002/jmri.21344. View

18.

KETY S . The theory and applications of the exchange of inert gas at the lungs and tissues. Pharmacol Rev. 1951; 3(1):1-41. View

19.

Barrett P, Bell B, Cobelli C, Golde H, Schumitzky A, Vicini P . SAAM II: Simulation, Analysis, and Modeling Software for tracer and pharmacokinetic studies. Metabolism. 1998; 47(4):484-92. DOI: 10.1016/s0026-0495(98)90064-6. View

20.

Loveless M, Lawson D, Collins M, Nadella M, Reimer C, Huszar D . Comparisons of the efficacy of a Jak1/2 inhibitor (AZD1480) with a VEGF signaling inhibitor (cediranib) and sham treatments in mouse tumors using DCE-MRI, DW-MRI, and histology. Neoplasia. 2012; 14(1):54-64. PMC: 3281942. DOI: 10.1593/neo.111478. View